Radiopharm Theranostics Limited ADR Company Profile
NASDAQ: RADXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Radiopharm Theranostics at a glance
Radiopharm Theranostics Limited ADR (NASDAQ: RADX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Carlton, VIC, Australia. Radiopharm Theranostics is led by Mr. Riccardo Canevari and employs about 14 people. At a market capitalization of $9.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001949257, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Radiopharm Theranostics do?
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. It is also developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; and RAD402, a PSA-mAb prostate cancer therapeutic. The company was incorporated in 2021 and is based in Carlton, Australia.
Business description based on the company's public filings.
Company information
- Legal name
- Radiopharm Theranostics Limited ADR
- Ticker
- NASDAQ: RADX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Riccardo Canevari
- Employees
- 14
- Headquarters
- 62 Lygon Street, Carlton, VIC, Australia
- Phone
- 61 3 9824 5254
- Website
- radiopharmtheranostics.com
- Market cap
- $9.86M
- SEC CIK
- 0001949257
Companies similar to Radiopharm Theranostics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ASBPAspire-Lakewood Holdings Inc. | 7.13 | -5.44% | $10.00M | vs RADX |
| CMMBChemomab Therapeutics Ltd. ADR | 1.19 | +4.39% | $9.58M | vs RADX |
| BFRIBiofrontera Inc. | 0.53 | -7.02% | $9.51M | vs RADX |
| AEONAEON Biopharma Inc. Class A | 0.123 | -7.59% | $10.35M | vs RADX |
| GDTCCytoMed Therapeutics Limited | 0.755 | -2.33% | $9.01M | vs RADX |
| CALCCalciMedica Inc. | 1.26 | +7.69% | $8.69M | vs RADX |
| OPTHOptimi Health Corp. | 1.51 | -13.71% | $8.65M | vs RADX |
| BIVIBioVie Inc. Class A | 0.80 | -12.07% | $8.58M | vs RADX |